The MST/Hippo pathway and cell death: A non-canonical affair

Genes

Volumn 7, Issue 6, 2016, Pages

  Fallahi, Emma ^a   O’Driscoll, Niamh A ^a   Matallanas, David ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Apoptosis; Cancer; Diabetes; Hippo pathway; LAST1 2; MST1 2; Neurodegenerative disease; RASSF1A; Signalling network; YAP

Indexed keywords

ATM PROTEIN; BIM PROTEIN; CHECKPOINT KINASE 1; CORE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; JANUS KINASE; K RAS PROTEIN; NOTCH RECEPTOR; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN KINASE YES; PROTEIN MDM2; PROTEIN NOXA; PROTEIN P53; PROTEIN P63; PROTEIN P73; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE MST1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RAS PROTEIN; SIRTUIN 1; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR YAP1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; WNT PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL DEATH; CELL MEMBRANE DEPOLARIZATION; CELL PROLIFERATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; DROSOPHILA MELANOGASTER; ENZYME ACTIVATION; ENZYME ACTIVE SITE; INSECT GENETICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR CLONING; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; ORGAN SIZE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 84975112370     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes7060028     Document Type: Review

References (218)

1. Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell. 2010, 19, 491-505
2. Matallanas, D.; Romano, D.; Hamilton, G.; Kolch, W.; O’Neill, E. A hippo in the ointment: Mst signaling beyond the fly. Cell Cycle 2008, 7, 879-884
3. Matallanas, D.; Romano, D.; Yee, K.; Meissl, K.; Kucerova, L.; Piazzolla, D.; Baccarini, M.; Vass, J.K.; Kolch, W.; O’Neill, E. Rassf1a elicits apoptosis through an mst2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol. Cell. 2007, 27, 962-975
4. Dong, J.; Feldmann, G.; Huang, J.; Wu, S.; Zhang, N.; Comerford, S.A.; Gayyed, M.F.; Anders, R.A.; Maitra, A.; Pan, D. Elucidation of a universal size-control mechanism in drosophila and mammals. Cell 2007, 130, 1120-1133
5. Varelas, X. The hippo pathway effectors taz and yap in development, homeostasis and disease. Developmet 2014, 141, 1614-1626
6. Yu, F.X.; Zhao, B.; Guan, K.L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 2015, 163, 811-828
7. Zhao, B.; Li, L.; Lei, Q.; Guan, K.L. The hippo-yap pathway in organ size control and tumorigenesis: An updated version. Genes Dev. 2010, 24, 862-874
8. Zhao, B.; Lei, Q.Y.; Guan, K.L. The hippo-yap pathway: New connections between regulation of organ size and cancer. Curr. Opin. Cell Biol. 2008, 20, 638-646
9. Meng, Z.; Moroishi, T.; Guan, K.L. Mechanisms of hippo pathway regulation. Genes Dev. 2016, 30, 1-17
10. O’Neill, E.E.; Matallanas, D.; Kolch, W. Mammalian sterile 20-like kinases in tumor suppression: An emerging pathway. Cancer Res. 2005, 65, 5485-5487
11. Radu, M.; Chernoff, J. The demstification of mammalian ste20 kinases. Curr. Biol. 2009, 19, R421-R425
12. Avruch, J.; Zhou, D.; Fitamant, J.; Bardeesy, N.; Mou, F.; Barrufet, L.R. Protein kinases of the hippo pathway: Regulation and substrates. Semin. Cell Dev. Biol. 2012, 23, 770-784
13. Visser, S.; Yang, X. Lats tumor suppressor: A new governor of cellular homeostasis. Cell Cycle 2010, 9, 3892-3903
14. Romano, D.; Matallanas, D.; Frederick, D.T.; Flaherty, K.T.; Kolch, W. One hippo and many masters: Differential regulation of the hippo pathway in cancer. Biochem. Soc. Trans. 2014, 42, 816-821
15. Romano, D.; Nguyen, L.K.; Matallanas, D.; Halasz, M.; Doherty, C.; Kholodenko, B.N.; Kolch, W. Protein interaction switches coordinate raf-1 and mst2/hippo signalling. Nat. Cell Biol. 2014, 16, 673-684
16. Imajo, M.; Miyatake, K.; Iimura, A.; Miyamoto, A.; Nishida, E. A molecular mechanism that links hippo signalling to the inhibition of wnt/beta-catenin signalling. EMBO J. 2012, 31, 1109-1122
17. Moon, R.T.; Gough, N.R. Beyond canonical: The wnt and β-catenin story. Sci. Signal. 2016
18. Ye, S.; Eisinger-Mathason, T.S. Targeting the hippo pathway: Clinical implications and therapeutics. Pharmacol. Res. 2016, 103, 270-278
19. Johnson, R.; Halder, G. The two faces of hippo: Targeting the hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 2014, 13, 63-79
20. Yuan, M.; Tomlinson, V.; Lara, R.; Holliday, D.; Chelala, C.; Harada, T.; Gangeswaran, R.; Manson-Bishop, C.; Smith, P.; Danovi, S.A.; et al. Yes-associated protein (yap) functions as a tumor suppressor in breast. Cell Death Differ. 2008, 15, 1752-1759
21. Wang, H.; Du, Y.C.; Zhou, X.J.; Liu, H.; Tang, S.C. The dual functions of yap-1 to promote and inhibit cell growth in human malignancy. Cancer Metastasis Rev. 2014, 33, 173-181
22. Tomlinson, V.; Gudmundsdottir, K.; Luong, P.; Leung, K.Y.; Knebel, A.; Basu, S. Jnk phosphorylates yes-associated protein (yap) to regulate apoptosis. Cell Death Dis. 2010
23. Bertini, E.; Oka, T.; Sudol, M.; Strano, S.; Blandino, G. Yap: At the crossroad between transformation and tumor suppression. Cell Cycle 2009, 8, 49-57
24. Strano, S.; Monti, O.; Pediconi, N.; Baccarini, A.; Fontemaggi, G.; Lapi, E.; Mantovani, F.; Damalas, A.; Citro, G.; Sacchi, A.; et al. The transcriptional coactivator yes-associated protein drives p73 gene-target specificity in response to DNA damage. Mol. Cell 2005, 18, 447-459
25. Du, X.; Yu, A.; Tao, W. The non-canonical hippo/mst pathway in lymphocyte development and functions. Acta Biochim. Biophys. Sin. 2015, 47, 60-64
26. Wong, R.S. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res. 2011
27. Kiraz, Y.; Adan, A.; Kartal Yandim, M.; Baran, Y. Major apoptotic mechanisms and genes involved in apoptosis. Tumour Biol. 2016
28. Scrace, S.F.; O’Neill, E. Rassf signalling and DNA damage: Monitoring the integrity of the genome? Mol. Biol. Int. 2012
29. Tumaneng, K.; Schlegelmilch, K.; Russell, R.C.; Yimlamai, D.; Basnet, H.; Mahadevan, N.; Fitamant, J.; Bardeesy, N.; Camargo, F.D.; Guan, K.L. Yap mediates crosstalk between the hippo and pi(3)k-tor pathways by suppressing pten via mir-29. Nat. Cell Biol. 2012, 14, 1322-1329
30. Su, T.; Bondar, T.; Zhou, X.; Zhang, C.; He, H.; Medzhitov, R. Two-signal requirement for growth-promoting function of yap in hepatocytes. Elife 2015
31. Lee, K.K.; Ohyama, T.; Yajima, N.; Tsubuki, S.; Yonehara, S. Mst, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J. Biol. Chem. 2001, 276, 19276-19285
32. Matallanas, D.; Romano, D.; Al-Mulla, F.; O’Neill, E.; Al-Ali, W.; Crespo, P.; Doyle, B.; Nixon, C.; Sansom, O.; Drosten, M.; et al. Mutant k-ras activation of the proapoptotic mst2 pathway is antagonized by wild-type k-ras. Mol. Cell 2011, 44, 893-906
33. Aylon, Y.; Michael, D.; Shmueli, A.; Yabuta, N.; Nojima, H.; Oren, M. A positive feedback loop between the p53 and lats2 tumor suppressors prevents tetraploidization. Genes Dev. 2006, 20, 2687-2700
34. Aylon, Y.; Ofir-Rosenfeld, Y.; Yabuta, N.; Lapi, E.; Nojima, H.; Lu, X.; Oren, M. The lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of aspp1. Genes Dev. 2010, 24, 2420-2429
35. Aylon, Y.; Yabuta, N.; Besserglick, H.; Buganim, Y.; Rotter, V.; Nojima, H.; Oren, M. Silencing of the lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant h-ras-driven cell transformation. Oncogene 2009, 28, 4469-4479
36. Cottini, F.; Hideshima, T.; Xu, C.; Sattler, M.; Dori, M.; Agnelli, L.; ten Hacken, E.; Bertilaccio, M.T.; Antonini, E.; Neri, A.; et al. Rescue of hippo coactivator yap1 triggers DNA damage-induced apoptosis in hematological cancers. Nat. Med. 2014, 20, 599-606
37. Staley, B.K.; Irvine, K.D. Hippo signaling in drosophila: Recent advances and insights. Dev. Dyn. 2012, 241, 3-15
38. Huang, J.; Wu, S.; Barrera, J.; Matthews, K.; Pan, D. The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating yorkie, the drosophila homolog of yap. Cell 2005, 122, 421-434
39. Green, D.R.; Evan, G.I. A matter of life and death. Cancer Cell 2002, 1, 19-30
40. Conlon, I.; Raff, M. Size control in animal development. Cell 1999, 96, 235-244
41. Harvey, K.; Tapon, N. The salvador-warts-hippo pathway-An emerging tumour-suppressor network. Nat. Rev. Cancer 2007, 7, 182-191
42. Irvine, K.D.; Harvey, K.F. Control of organ growth by patterning and hippo signaling in drosophila. Cold Spring Harb. Perspect Biol. 2015
43. Poon, C.L.; Lin, J.I.; Zhang, X.; Harvey, K.F. The sterile 20-like kinase tao-1 controls tissue growth by regulating the salvador-warts-hippo pathway. Dev. Cell 2011, 21, 896-906
44. Polesello, C.; Huelsmann, S.; Brown, N.H.; Tapon, N. The drosophila rassf homolog antagonizes the hippo pathway. Curr. Biol. 2006, 16, 2459-2465
45. Ribeiro, P.S.; Josue, F.; Wepf, A.; Wehr, M.C.; Rinner, O.; Kelly, G.; Tapon, N.; Gstaiger, M. Combined functional genomic and proteomic approaches identify a pp2a complex as a negative regulator of hippo signaling. Mol. Cell. 2010, 39, 521-534
46. Donninger, H.; Vos, M.D.; Clark, G.J. The rassf1a tumor suppressor. J. Cell Sci. 2007, 120, 3163-3172
47. Harvey, K.F.; Zhang, X.; Thomas, D.M. The hippo pathway and human cancer. Nat. Rev. Cancer 2013, 13, 246-257
48. Rauskolb, C.; Pan, G.; Reddy, B.V.; Oh, H.; Irvine, K.D. Zyxin links fat signaling to the hippo pathway. PLoS Biol. 2011
49. Gilbert, M.M.; Tipping, M.; Veraksa, A.; Moberg, K.H. A screen for conditional growth suppressor genes identifies the drosophila homolog of hd-ptp as a regulator of the oncoprotein yorkie. Dev. Cell 2011, 20, 700-712
50. Zhang, X.; Milton, C.C.; Poon, C.L.; Hong, W.; Harvey, K.F. Wbp2 cooperates with yorkie to drive tissue growth downstream of the salvador-warts-hippo pathway. Cell Death Differ. 2011, 18, 1346-1355
51. Udan, R.S.; Kango-Singh, M.; Nolo, R.; Tao, C.; Halder, G. Hippo promotes proliferation arrest and apoptosis in the salvador/warts pathway. Nat. Cell Biol. 2003, 5, 914-920
52. Harvey, K.F.; Pfleger, C.M.; Hariharan, I.K. The drosophila mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 2003, 114, 457-467
53. Pantalacci, S.; Tapon, N.; Leopold, P. The salvador partner hippo promotes apoptosis and cell-cycle exit in drosophila. Nat. Cell Biol. 2003, 5, 921-927
54. Colombani, J.; Polesello, C.; Josue, F.; Tapon, N. Dmp53 activates the hippo pathway to promote cell death in response to DNA damage. Curr. Biol. 2006, 16, 1453-1458
55. Zhang, W.; Cohen, S.M. The hippo pathway acts via p53 and micrornas to control proliferation and proapoptotic gene expression during tissue growth. Biol. Open 2013, 2, 822-828
56. Kwon, Y.; Vinayagam, A.; Sun, X.; Dephoure, N.; Gygi, S.P.; Hong, P.; Perrimon, N. The hippo signaling pathway interactome. Science 2013, 342, 737-740
57. Mikeladze-Dvali, T.; Wernet, M.F.; Pistillo, D.; Mazzoni, E.O.; Teleman, A.A.; Chen, Y.W.; Cohen, S.; Desplan, C. The growth regulators warts/lats and melted interact in a bistable loop to specify opposite fates in drosophila r8 photoreceptors. Cell 2005, 122, 775-787
58. Hsiao, H.Y.; Jukam, D.; Johnston, R.; Desplan, C. The neuronal transcription factor erect wing regulates specification and maintenance of drosophila r8 photoreceptor subtypes. Dev. Biol. 2013, 381, 482-490
59. Emoto, K.; Parrish, J.Z.; Jan, L.Y.; Jan, Y.N. The tumour suppressor hippo acts with the ndr kinases in dendritic tiling and maintenance. Nature 2006, 443, 210-213
60. Parrish, J.Z.; Emoto, K.; Jan, L.Y.; Jan, Y.N. Polycomb genes interact with the tumor suppressor genes hippo and warts in the maintenance of drosophila sensory neuron dendrites. Genes Dev. 2007, 21, 956-972
61. Peng, H.W.; Slattery, M.; Mann, R.S. Transcription factor choice in the hippo signaling pathway: Homothorax and yorkie regulation of the microrna bantam in the progenitor domain of the drosophila eye imaginal disc. Genes Dev. 2009, 23, 2307-2319
62. Zhang, T.; Zhou, Q.; Pignoni, F. Yki/yap, sd/tead and hth/meis control tissue specification in the drosophila eye disc epithelium. PLoS ONE 2011
63. Robbins, R.M.; Gbur, S.C.; Beitel, G.J. Non-canonical roles for yorkie and drosophila inhibitor of apoptosis 1 in epithelial tube size control. PLoS ONE 2014
64. Oh, H.; Irvine, K.D. In vivo regulation of yorkie phosphorylation and localization. Development 2008, 135, 1081-1088
65. Oh, H.; Irvine, K.D. In vivo analysis of yorkie phosphorylation sites. Oncogene 2009, 28, 1916-1927
66. Strano, S.; Blandino, G. Yap1 meets tumor suppression. Mol. Cell 2007, 27, 863-864
67. Camargo, F.D.; Gokhale, S.; Johnnidis, J.B.; Fu, D.; Bell, G.W.; Jaenisch, R.; Brummelkamp, T.R. Yap1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 2007, 17, 2054-2060
68. Zhou, D.; Conrad, C.; Xia, F.; Park, J.S.; Payer, B.; Yin, Y.; Lauwers, G.Y.; Thasler, W.; Lee, J.T.; Avruch, J.; et al. Mst1 and mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the yap1 oncogene. Cancer Cell 2009, 16, 425-438
69. Lee, J.H.; Kim, T.S.; Yang, T.H.; Koo, B.K.; Oh, S.P.; Lee, K.P.; Oh, H.J.; Lee, S.H.; Kong, Y.Y.; Kim, J.M.; et al. A crucial role of ww45 in developing epithelial tissues in the mouse. EMBO J. 2008, 27, 1231-1242
70. Vassilev, A.; Kaneko, K.J.; Shu, H.; Zhao, Y.; DePamphilis, M.L. Tead/tef transcription factors utilize the activation domain of yap65, a src/yes-associated protein localized in the cytoplasm. Genes Dev. 2001, 15, 1229-1241
71. Zhao, B.; Ye, X.; Yu, J.; Li, L.; Li, W.; Li, S.; Yu, J.; Lin, J.D.; Wang, C.Y.; Chinnaiyan, A.M.; et al. Tead mediates yap-dependent gene induction and growth control. Genes Dev. 2008, 22, 1962-1971
72. Couzens, A.L.; Knight, J.D.; Kean, M.J.; Teo, G.; Weiss, A.; Dunham, W.H.; Lin, Z.Y.; Bagshaw, R.D.; Sicheri, F.; Pawson, T.; et al. Protein interaction network of the mammalian hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci. Signal. 2013
73. Feng, X.; Chen, Q.; Gutkind, J.S. Oncotargeting G proteins: The hippo in the room. Oncotarget 2014, 5, 10997-10999
74. Hauri, S.; Wepf, A.; van Drogen, A.; Varjosalo, M.; Tapon, N.; Aebersold, R.; Gstaiger, M. Interaction proteome of human hippo signaling: Modular control of the co-activator yap1. Mol. Syst. Biol. 2013
75. Visser, S.; Yang, X. Identification of lats transcriptional targets in hela cells using whole human genome oligonucleotide microarray. Gene 2010, 449, 22-29
76. Weiss, E.L. Hippo unleashed! Proteome-scale analysis reveals new views of hippo pathway biology. Sci. Signal. 2013
77. Kodaka, M.; Hata, Y. The mammalian hippo pathway: Regulation and function of yap1 and taz. Cell Mol. Life Sci. 2015, 72, 285-306
78. Kawahara, M.; Hori, T.; Chonabayashi, K.; Oka, T.; Sudol, M.; Uchiyama, T. Kpm/lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73. Blood 2008, 112, 3856-3866
79. Oka, T.; Mazack, V.; Sudol, M. Mst2 and lats kinases regulate apoptotic function of yes kinase-associated protein (yap). J. Biol. Chem. 2008, 283, 27534-27546
80. Preisinger, C.; von Kriegsheim, A.; Matallanas, D.; Kolch, W. Proteomics and phosphoproteomics for the mapping of cellular signalling networks. Proteomics 2008, 8, 4402-4415
81. O’Neill, E.; Rushworth, L.; Baccarini, M.; Kolch, W. Role of the kinase mst2 in suppression of apoptosis by the proto-oncogene product raf-1. Science 2004, 306, 2267-2270
82. Creasy, C.L.; Ambrose, D.M.; Chernoff, J. The ste20-like protein kinase, mst1, dimerizes and contains an inhibitory domain. J. Biol. Chem. 1996, 271, 21049-21053
83. Praskova, M.; Khoklatchev, A.; Ortiz-Vega, S.; Avruch, J. Regulation of the mst1 kinase by autophosphorylation, by the growth inhibitory proteins, rassf1 and nore1, and by ras. Biochem. J. 2004, 381, 453-462
84. Khokhlatchev, A.; Rabizadeh, S.; Xavier, R.; Nedwidek, M.; Chen, T.; Zhang, X.F.; Seed, B.; Avruch, J. Identification of a novel ras-regulated proapoptotic pathway. Curr. Biol. 2002, 12, 253-265
85. Oh, H.J.; Lee, K.K.; Song, S.J.; Jin, M.S.; Song, M.S.; Lee, J.H.; Im, C.R.; Lee, J.O.; Yonehara, S.; Lim, D.S. Role of the tumor suppressor rassf1a in mst1-mediated apoptosis. Cancer Res. 2006, 66, 2562-2569
86. Guo, C.; Tommasi, S.; Liu, L.; Yee, J.K.; Dammann, R.; Pfeifer, G.P. Rassf1a is part of a complex similar to the drosophila hippo/salvador/lats tumor-suppressor network. Curr. Biol. 2007, 17, 700-705
87. Basu, S.; Totty, N.F.; Irwin, M.S.; Sudol, M.; Downward, J. Akt phosphorylates the yes-associated protein, yap, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 2003, 11, 11-23
88. Lapi, E.; Di Agostino, S.; Donzelli, S.; Gal, H.; Domany, E.; Rechavi, G.; Pandolfi, P.P.; Givol, D.; Strano, S.; Lu, X.; et al. Pml, yap, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol. Cell 2008, 32, 803-814
89. Tufail, R.; Jorda, M.; Zhao, W.; Reis, I.; Nawaz, Z. Loss of yes-associated protein (yap) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas. Breast Cancer Res. Treat. 2012, 131, 743-750
90. Kolch, W.; Halasz, M.; Granovskaya, M.; Kholodenko, B.N. The dynamic control of signal transduction networks in cancer cells. Nat. Rev. Cancer 2015, 15, 515-527
91. Mauviel, A.; Nallet-Staub, F.; Varelas, X. Integrating developmental signals: A hippo in the (path)way. Oncogene 2012, 31, 1743-1756
92. Varelas, X.; Miller, B.W.; Sopko, R.; Song, S.; Gregorieff, A.; Fellouse, F.A.; Sakuma, R.; Pawson, T.; Hunziker, W.; McNeill, H.; et al. The hippo pathway regulates wnt/beta-catenin signaling. Dev. Cell 2010, 18, 579-591
93. Romano, D.; Matallanas, D.; Weitsman, G.; Preisinger, C.; Ng, T.; Kolch, W. Proapoptotic kinase mst2 coordinates signaling crosstalk between rassf1a, raf-1, and akt. Cancer Res. 2010, 70, 1195-1203
94. Volodko, N.; Gordon, M.; Salla, M.; Ghazaleh, H.A.; Baksh, S. Rassf tumor suppressor gene family: Biological functions and regulation. FEBS Lett. 2014, 588, 2671-2684
95. Fernandes, M.S.; Carneiro, F.; Oliveira, C.; Seruca, R. Colorectal cancer and rassf family-A special emphasis on rassf1a. Int. J. Cancer 2013, 132, 251-258
96. Richter, A.M.; Pfeifer, G.P.; Dammann, R.H. The rassf proteins in cancer; from epigenetic silencing to functional characterization. Biochim. Biophys. Acta 2009, 1796, 114-128
97. Van der Weyden, L.; Adams, D.J. The ras-association domain family (rassf) members and their role in human tumourigenesis. Biochim. Biophys. Acta 2007, 1776, 58-85
98. Wang, W.; Li, X.; Huang, J.; Feng, L.; Dolinta, K.G.; Chen, J. Defining the protein-protein interaction network of the human hippo pathway. Mol. Cell Proteomics 2014, 13, 119-131
99. Hauri, S.; Wepf, A.; van Drogen, A.; Varjosalo, M.; Tapon, N.; Aebersold, R.; Gstaiger, M. Interaction proteome of human hippo signaling: Modular control of the co-activator yap1. Mol. Syst. Biol. 2013
100. Cooper, W.N.; Hesson, L.B.; Matallanas, D.; Dallol, A.; von Kriegsheim, A.; Ward, R.; Kolch, W.; Latif, F. Rassf2 associates with and stabilizes the proapoptotic kinase mst2. Oncogene 2009, 28, 2988-2998
101. Agathanggelou, A.; Cooper, W.N.; Latif, F. Role of the ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res. 2005, 65, 3497-3508
102. Grawenda, A.M.; O’Neill, E. Clinical utility of rassf1a methylation in human malignancies. Br. J. Cancer 2015, 113, 372-381
103. Reeves, M.E.; Firek, M.; Chen, S.T.; Amaar, Y. The rassf1 gene and the opposing effects of the rassf1a and rassf1c isoforms on cell proliferation and apoptosis. Mol. Biol. Int. 2013
104. Malpeli, G.; Amato, E.; Dandrea, M.; Fumagalli, C.; Debattisti, V.; Boninsegna, L.; Pelosi, G.; Falconi, M.; Scarpa, A. Methylation-associated down-regulation of rassf1a and up-regulation of rassf1c in pancreatic endocrine tumors. BMC Cancer 2011
105. Kolch, W. Coordinating erk/mapk signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 2005, 6, 827-837
106. Aoyama, Y.; Avruch, J.; Zhang, X.F. Nore1 inhibits tumor cell growth independent of ras or the mst1/2 kinases. Oncogene 2004, 23, 3426-3433
107. Avruch, J.; Praskova, M.; Ortiz-Vega, S.; Liu, M.; Zhang, X.F. Nore1 and rassf1 regulation of cell proliferation and of the mst1/2 kinases. Meth. Enzymol. 2006, 407, 290-310
108. Zhou, X.H.; Yang, C.Q.; Zhang, C.L.; Gao, Y.; Yuan, H.B.; Wang, C. Rassf5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of mst1/lats1 signaling. Oncol. Rep. 2014, 32, 1505-1512
109. Dubois, F.; Keller, M.; Calvayrac, O.; Soncin, F.; Hoa, L.; Hergovich, A.; Parrini, M.C.; Mazieres, J.; Vaisse-Lesteven, M.; Camonis, J.; et al. Rassf1a suppresses the invasion and metastatic potential of human non-small cell lung cancer cells by inhibiting yap activation through the gef-h1/rhob pathway. Cancer Res. 2016, 76, 1627-1640
110. Kohli, P.; Bartram, M.P.; Habbig, S.; Pahmeyer, C.; Lamkemeyer, T.; Benzing, T.; Schermer, B.; Rinschen, M.M. Label-free quantitative proteomic analysis of the yap/taz interactome. Am. J. Physiol. Cell Physiol. 2014, 306, C805-C818
111. Feig, L.A.; Buchsbaum, R.J. Cell signaling: Life or death decisions of ras proteins. Curr. Biol. 2002, 12, R259-R261
112. Ortiz-Vega, S.; Khokhlatchev, A.; Nedwidek, M.; Zhang, X.F.; Dammann, R.; Pfeifer, G.P.; Avruch, J. The putative tumor suppressor rassf1a homodimerizes and heterodimerizes with the ras-gtp binding protein nore1. Oncogene 2002, 21, 1381-1390
113. Cox, A.D.; Der, C.J. The dark side of ras: Regulation of apoptosis. Oncogene 2003, 22, 8999-9006
114. Matallanas, D.; Birtwistle, M.; Romano, D.; Zebisch, A.; Rauch, J.; von Kriegsheim, A.; Kolch, W. Raf family kinases: Old dogs have learned new tricks. Genes Cancer 2011, 2, 232-260
115. Romano, D.; Maccario, H.; Doherty, C.; Quinn, N.P.; Kolch, W.; Matallanas, D. The differential effects of wild-type and mutated k-ras on mst2 signaling are determined by k-ras activation kinetics. Mol. Cell. Biol. 2013, 33, 1859-1868
116. Hong, X.; Nguyen, H.T.; Chen, Q.; Zhang, R.; Hagman, Z.; Voorhoeve, P.M.; Cohen, S.M. Opposing activities of the ras and hippo pathways converge on regulation of yap protein turnover. EMBO J. 2014, 33, 2447-2457
117. Garcia-Rendueles, M.E.; Ricarte-Filho, J.C.; Untch, B.R.; Landa, I.; Knauf, J.A.; Voza, F.; Smith, V.E.; Ganly, I.; Taylor, B.S.; Persaud, Y.; et al. Nf2 loss promotes oncogenic ras-induced thyroid cancers via yap-dependent transactivation of ras proteins and sensitizes them to mek inhibition. Cancer Discov. 2015, 5, 1178-1193
118. Jia, J.; Li, C.; Luo, S.; Liu-Smith, F.; Yang, J.; Wang, X.; Wang, N.; Lai, B.; Lei, T.; Wang, Q.; et al. Yes-associated protein contributes to the development of human cutaneous squamous cell carcinoma via activation of ras. J. Investig. Dermatol. 2016, 136, 1267-1277
119. Kapoor, A.; Yao, W.; Ying, H.; Hua, S.; Liewen, A.; Wang, Q.; Zhong, Y.; Wu, C.J.; Sadanandam, A.; Hu, B.; et al. Yap1 activation enables bypass of oncogenic kras addiction in pancreatic cancer. Cell 2014, 158, 185-197
120. Lin, L.; Sabnis, A.J.; Chan, E.; Olivas, V.; Cade, L.; Pazarentzos, E.; Asthana, S.; Neel, D.; Yan, J.J.; Lu, X.; et al. The hippo effector yap promotes resistance to raf-and mek-targeted cancer therapies. Nat. Genet. 2015, 47, 250-256
121. Kilili, G.K.; Kyriakis, J.M. Mammalian ste20-like kinase (mst2) indirectly supports raf-1/erk pathway activity via maintenance of protein phosphatase-2a catalytic subunit levels and consequent suppression of inhibitory raf-1 phosphorylation. J. Biol. Chem. 2010, 285, 15076-15087
122. Rauch, J.; O’Neill, E.; Mack, B.; Matthias, C.; Munz, M.; Kolch, W.; Gires, O. Heterogeneous nuclear ribonucleoprotein h blocks mst2-mediated apoptosis in cancer cells by regulating a-raf transcription. Cancer Res. 2010, 70, 1679-1688
123. Lee, S.J.; Lee, M.H.; Kim, D.W.; Lee, S.; Huang, S.; Ryu, M.J.; Kim, Y.K.; Kim, S.J.; Kim, S.J.; Hwang, J.H.; et al. Cross-regulation between oncogenic braf(v600e) kinase and the mst1 pathway in papillary thyroid carcinoma. PLoS ONE 2011
124. Dhillon, A.S.; Meikle, S.; Yazici, Z.; Eulitz, M.; Kolch, W. Regulation of raf-1 activation and signalling by dephosphorylation. EMBO J. 2002, 21, 64-71
125. Zhang, W.; Nandakumar, N.; Shi, Y.; Manzano, M.; Smith, A.; Graham, G.; Gupta, S.; Vietsch, E.E.; Laughlin, S.Z.; Wadhwa, M.; et al. Downstream of mutant kras, the transcription regulator yap is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci. Signal. 2014
126. Chappell, W.H.; Steelman, L.S.; Long, J.M.; Kempf, R.C.; Abrams, S.L.; Franklin, R.A.; Basecke, J.; Stivala, F.; Donia, M.; Fagone, P.; et al. Ras/raf/mek/erk and pi3k/pten/akt/mtor inhibitors: Rationale and importance to inhibiting these pathways in human health. Oncotarget 2011, 2, 135-164
127. Kim, D.; Shu, S.; Coppola, M.D.; Kaneko, S.; Yuan, Z.Q.; Cheng, J.Q. Regulation of proapoptotic mammalian ste20-like kinase mst2 by the igf1-akt pathway. PLoS ONE 2010
128. Cinar, B.; Fang, P.K.; Lutchman, M.; di Vizio, D.; Adam, R.M.; Pavlova, N.; Rubin, M.A.; Yelick, P.C.; Freeman, M.R. The pro-apoptotic kinase mst1 and its caspase cleavage products are direct inhibitors of akt1. EMBO J. 2007, 26, 4523-4534
129. Carnero, A.; Blanco-Aparicio, C.; Renner, O.; Link, W.; Leal, J.F. The pten/pi3k/akt signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets 2008, 8, 187-198
130. Shi, Y.; Paluch, B.E.; Wang, X.; Jiang, X. Pten at a glance. J. Cell Sci. 2012, 125, 4687-4692
131. Pefani, D.E.; O’Neill, E. Hippo pathway and protection of genome stability in response to DNA damage. FEBS J. 2016, 283, 1392-1403
132. Hamilton, G.; Yee, K.S.; Scrace, S.; O’Neill, E. Atm regulates a rassf1a-dependent DNA damage response. Curr. Biol. 2009, 19, 2020-2025
133. Pefani, D.E.; Latusek, R.; Pires, I.; Grawenda, A.M.; Yee, K.S.; Hamilton, G.; van der Weyden, L.; Esashi, F.; Hammond, E.M.; O’Neill, E. Rassf1a-lats1 signalling stabilizes replication forks by restricting cdk2-mediated phosphorylation of brca2. Nat. Cell Biol. 2015
134. Keshet, R.; Adler, J.; Ricardo Lax, I.; Shanzer, M.; Porat, Z.; Reuven, N.; Shaul, Y. C-abl antagonizes the yap oncogenic function. Cell Death Differ. 2015, 22, 935-945
135. Hergovich, A. Regulation and functions of mammalian lats/ndr kinases: Looking beyond canonical hippo signalling. Cell Biosci. 2013
136. Hergovich, A. The roles of ndr protein kinases in hippo signalling. Genes 2016
137. Hergovich, A. Mammalian hippo signalling: A kinase network regulated by protein-protein interactions. Biochem. Soc. Trans. 2012, 40, 124-128
138. Creasy, C.L.; Chernoff, J. Cloning and characterization of a member of the mst subfamily of ste20-like kinases. Gene 1995, 167, 303-306
139. Creasy, C.L.; Chernoff, J. Cloning and characterization of a human protein kinase with homology to ste20. J. Biol. Chem. 1995, 270, 21695-21700
140. Sanchez-Sanz, G.; Matallanas, D.; Nguyen, L.K.; Kholodenko, B.N.; Rosta, E.; Kolch, W.; Buchete, N.V. Mst2-rassf protein-protein interactions through sarah domains. Brief. Bioinform. 2015
141. Graves, J.D.; Gotoh, Y.; Draves, K.E.; Ambrose, D.; Han, D.K.; Wright, M.; Chernoff, J.; Clark, E.A.; Krebs, E.G. Caspase-mediated activation and induction of apoptosis by the mammalian ste20-like kinase mst1. EMBO J. 1998, 17, 2224-2234
142. Glantschnig, H.; Rodan, G.A.; Reszka, A.A. Mapping of mst1 kinase sites of phosphorylation. Activation and autophosphorylation. J. Biol. Chem. 2002, 277, 42987-42996
143. Matsumoto, H.; Murakami, Y.; Kataoka, K.; Lin, H.; Connor, K.M.; Miller, J.W.; Zhou, D.; Avruch, J.; Vavvas, D.G. Mammalian ste20-like kinase 2, not kinase 1, mediates photoreceptor cell death during retinal detachment. Cell Death Dis. 2014
144. Ura, S.; Masuyama, N.; Graves, J.D.; Gotoh, Y. Mst1-jnk promotes apoptosis via caspase-dependent and independent pathways. Genes Cells 2001, 6, 519-530
145. Cheung, W.L.; Ajiro, K.; Samejima, K.; Kloc, M.; Cheung, P.; Mizzen, C.A.; Beeser, A.; Etkin, L.D.; Chernoff, J.; Earnshaw, W.C.; et al. Apoptotic phosphorylation of histone h2b is mediated by mammalian sterile twenty kinase. Cell 2003, 113, 507-517
146. Vichalkovski, A.; Gresko, E.; Cornils, H.; Hergovich, A.; Schmitz, D.; Hemmings, B.A. Ndr kinase is activated by rassf1a/mst1 in response to fas receptor stimulation and promotes apoptosis. Curr. Biol. 2008, 18, 1889-1895
147. Song, J.J.; Lee, Y.J. Differential cleavage of mst1 by caspase-7/-3 is responsible for trail-induced activation of the mapk superfamily. Cell. Signal. 2008, 20, 892-906
148. Song, M.S.; Song, S.J.; Kim, S.Y.; Oh, H.J.; Lim, D.S. The tumour suppressor rassf1a promotes mdm2 self-ubiquitination by disrupting the mdm2-daxx-hausp complex. EMBO J. 2008, 27, 1863-1874
149. Yun, H.J.; Yoon, J.H.; Lee, J.K.; Noh, K.T.; Yoon, K.W.; Oh, S.P.; Oh, H.J.; Chae, J.S.; Hwang, S.G.; Kim, E.H.; et al. Daxx mediates activation-induced cell death in microglia by triggering mst1 signalling. EMBO J. 2011, 30, 2465-2476
150. Navas, T.A.; Baldwin, D.T.; Stewart, T.A. Rip2 is a raf1-activated mitogen-activated protein kinase kinase. J. Biol. Chem. 1999, 274, 33684-33690
151. Xu, S.; Wu, H.; Nie, H.; Yue, L.; Jiang, H.; Xiao, S.; Li, Y. Aif downregulation and its interaction with stk3 in renal cell carcinoma. PLoS ONE 2014
152. Ardestani, A.; Maedler, K. Mst1: A promising therapeutic target to restore functional beta cell mass in diabetes. Diabetologia 2016
153. Pan, B.; Yang, L.; Wang, J.; Wang, Y.; Wang, J.; Zhou, X.; Yin, X.; Zhang, Z.; Zhao, D. C-abl tyrosine kinase mediates neurotoxic prion peptide-induced neuronal apoptosis via regulating mitochondrial homeostasis. Mol. Neurobiol. 2014, 49, 1102-1116
154. Del Re, D.P.; Matsuda, T.; Zhai, P.; Maejima, Y.; Jain, M.R.; Liu, T.; Li, H.; Hsu, C.P.; Sadoshima, J. Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of bcl-xl. Mol. Cell 2014, 54, 639-650
155. Yuan, F.; Xie, Q.; Wu, J.; Bai, Y.; Mao, B.; Dong, Y.; Bi, W.; Ji, G.; Tao, W.; Wang, Y.; et al. Mst1 promotes apoptosis through regulating sirt1-dependent p53 deacetylation. J. Biol. Chem. 2011, 286, 6940-6945
156. Lehtinen, M.K.; Yuan, Z.; Boag, P.R.; Yang, Y.; Villen, J.; Becker, E.B.; DiBacco, S.; de la Iglesia, N.; Gygi, S.; Blackwell, T.K.; et al. A conserved mst-foxo signaling pathway mediates oxidative-stress responses and extends life span. Cell 2006, 125, 987-1001
157. Yuan, Z.; Lehtinen, M.K.; Merlo, P.; Villen, J.; Gygi, S.; Bonni, A. Regulation of neuronal cell death by mst1-foxo1 signaling. J. Biol. Chem. 2009, 284, 11285-11292
158. Sanphui, P.; Biswas, S.C. Foxo3a is activated and executes neuron death via bim in response to beta-amyloid. Cell Death Dis. 2013
159. Valis, K.; Prochazka, L.; Boura, E.; Chladova, J.; Obsil, T.; Rohlena, J.; Truksa, J.; Dong, L.F.; Ralph, S.J.; Neuzil, J. Hippo/mst1 stimulates transcription of the proapoptotic mediator noxa in a foxo1-dependent manner. Cancer Res. 2011, 71, 946-954
160. Jang, S.W.; Yang, S.J.; Srinivasan, S.; Ye, K. Akt phosphorylates msti and prevents its proteolytic activation, blocking foxo3 phosphorylation and nuclear translocation. J. Biol. Chem. 2007, 282, 30836-30844
161. Lee, J.K.; Shin, J.H.; Hwang, S.G.; Gwag, B.J.; McKee, A.C.; Lee, J.; Kowall, N.W.; Ryu, H.; Lim, D.S.; Choi, E.J. Mst1 functions as a key modulator of neurodegeneration in a mouse model of als. Proc. Natl. Acad. Sci. USA 2013, 110, 12066-12071
162. Xiao, L.; Chen, D.; Hu, P.; Wu, J.; Liu, W.; Zhao, Y.; Cao, M.; Fang, Y.; Bi, W.; Zheng, Z.; et al. The c-abl-mst1 signaling pathway mediates oxidative stress-induced neuronal cell death. J. Neurosci. 2011, 31, 9611-9619
163. Liu, W.; Wu, J.; Xiao, L.; Bai, Y.; Qu, A.; Zheng, Z.; Yuan, Z. Regulation of neuronal cell death by c-abl-hippo/mst2 signaling pathway. PLoS ONE 2012
164. Wilkinson, D.S.; Jariwala, J.S.; Anderson, E.; Mitra, K.; Meisenhelder, J.; Chang, J.T.; Ideker, T.; Hunter, T.; Nizet, V.; Dillin, A.; et al. Phosphorylation of lc3 by the hippo kinases stk3/stk4 is essential for autophagy. Mol. Cell. 2015, 57, 55-68
165. Lee, G.J.; Yan, L.; Vatner, D.E.; Vatner, S.F. Mst1 inhibition rescues beta1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis. Basic. Res. Cardiol. 2015
166. Yabuta, N.; Fujii, T.; Copeland, N.G.; Gilbert, D.J.; Jenkins, N.A.; Nishiguchi, H.; Endo, Y.; Toji, S.; Tanaka, H.; Nishimune, Y.; et al. Structure, expression, and chromosome mapping of lats2, a mammalian homologue of the drosophila tumor suppressor gene lats/warts. Genomics 2000, 63, 263-270
167. Nishiyama, Y.; Hirota, T.; Morisaki, T.; Hara, T.; Marumoto, T.; Iida, S.; Makino, K.; Yamamoto, H.; Hiraoka, T.; Kitamura, N.; et al. A human homolog of drosophila warts tumor suppressor, h-warts, localized to mitotic apparatus and specifically phosphorylated during mitosis. FEBS Lett. 1999, 459, 159-165
168. Hori, T.; Takaori-Kondo, A.; Kamikubo, Y.; Uchiyama, T. Molecular cloning of a novel human protein kinase, kpm, that is homologous to warts/lats, a drosophila tumor suppressor. Oncogene 2000, 19, 3101-3109
169. Xia, H.; Qi, H.; Li, Y.; Pei, J.; Barton, J.; Blackstad, M.; Xu, T.; Tao, W. Lats1 tumor suppressor regulates g2/m transition and apoptosis. Oncogene 2002, 21, 1233-1241
170. Kuninaka, S.; Nomura, M.; Hirota, T.; Iida, S.; Hara, T.; Honda, S.; Kunitoku, N.; Sasayama, T.; Arima, Y.; Marumoto, T.; et al. The tumor suppressor warts activates the omi/htra2-dependent pathway of cell death. Oncogene 2005, 24, 5287-5298
171. Ke, H.; Pei, J.; Ni, Z.; Xia, H.; Qi, H.; Woods, T.; Kelekar, A.; Tao, W. Putative tumor suppressor lats2 induces apoptosis through downregulation of bcl-2 and bcl-x(l). Exp. Cell Res. 2004, 298, 329-338
172. Iida, S.; Hirota, T.; Morisaki, T.; Marumoto, T.; Hara, T.; Kuninaka, S.; Honda, S.; Kosai, K.; Kawasuji, M.; Pallas, D.C.; et al. Tumor suppressor warts ensures genomic integrity by regulating both mitotic progression and g1 tetraploidy checkpoint function. Oncogene 2004, 23, 5266-5274
173. Vakifahmetoglu, H.; Olsson, M.; Zhivotovsky, B. Death through a tragedy: Mitotic catastrophe. Cell Death Differ. 2008, 15, 1153-1162
174. Sudol, M.; Bork, P.; Einbond, A.; Kastury, K.; Druck, T.; Negrini, M.; Huebner, K.; Lehman, D. Characterization of the mammalian yap (yes-associated protein) gene and its role in defining a novel protein module, the ww domain. J. Biol. Chem. 1995, 270, 14733-14741
175. Hao, Y.; Chun, A.; Cheung, K.; Rashidi, B.; Yang, X. Tumor suppressor lats1 is a negative regulator of oncogene yap. J. Biol. Chem. 2008, 283, 5496-5509
176. Piccolo, S.; Dupont, S.; Cordenonsi, M. The biology of yap/taz: Hippo signaling and beyond. Physiol. Rev. 2014, 94, 1287-1312
177. Chen, Q.; Zhang, N.; Xie, R.; Wang, W.; Cai, J.; Choi, K.S.; David, K.K.; Huang, B.; Yabuta, N.; Nojima, H.; et al. Homeostatic control of hippo signaling activity revealed by an endogenous activating mutation in yap. Genes Dev. 2015, 29, 1285-1297
178. Fausti, F.; Di Agostino, S.; Cioce, M.; Bielli, P.; Sette, C.; Pandolfi, P.P.; Oren, M.; Sudol, M.; Strano, S.; Blandino, G. Atm kinase enables the functional axis of yap, pml and p53 to ameliorate loss of werner protein-mediated oncogenic senescence. Cell Death Differ. 2013, 20, 1498-1509
179. Zagurovskaya, M.; Shareef, M.M.; Das, A.; Reeves, A.; Gupta, S.; Sudol, M.; Bedford, M.T.; Prichard, J.; Mohiuddin, M.; Ahmed, M.M. Egr-1 forms a complex with yap-1 and upregulates bax expression in irradiated prostate carcinoma cells. Oncogene 2009, 28, 1121-1131
180. Lee, K.K.; Yonehara, S. Identification of mechanism that couples multisite phosphorylation of yes-associated protein (yap) with transcriptional coactivation and regulation of apoptosis. J. Biol. Chem. 2012, 287, 9568-9578
181. Zhao, B.; Li, L.; Tumaneng, K.; Wang, C.Y.; Guan, K.L. A coordinated phosphorylation by lats and ck1 regulates yap stability through scf(beta-trcp). Genes Dev. 2010, 24, 72-85
182. Kuser-Abali, G.; Alptekin, A.; Lewis, M.; Garraway, I.P.; and Cinar, B. Yap1 and ar interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer. Nat. Commun. 2014
183. Rosenbluh, J.; Nijhawan, D.; Cox, A.G.; Li, X.; Neal, J.T.; Schafer, E.J.; Zack, T.I.; Wang, X.; Tsherniak, A.; Schinzel, A.C.; et al. Beta-catenin-driven cancers require a yap1 transcriptional complex for survival and tumorigenesis. Cell 2012, 151, 1457-1473
184. Kim, M.; Kim, T.; Johnson, R.L.; Lim, D.S. Transcriptional co-repressor function of the hippo pathway transducers yap and taz. Cell Rep. 2015, 11, 270-282
185. Landin Malt, A.; Cagliero, J.; Legent, K.; Silber, J.; Zider, A.; Flagiello, D. Alteration of tead1 expression levels confers apoptotic resistance through the transcriptional up-regulation of livin. PLoS ONE 2012
186. Salah, Z.; Itzhaki, E.; Aqeilan, R.I. The ubiquitin e3 ligase itch enhances breast tumor progression by inhibiting the hippo tumor suppressor pathway. Oncotarget 2014, 5, 10886-10900
187. Aqeilan, R.I.; Donati, V.; Palamarchuk, A.; Trapasso, F.; Kaou, M.; Pekarsky, Y.; Sudol, M.; Croce, C.M. Ww domain-containing proteins, wwox and yap, compete for interaction with erbb-4 and modulate its transcriptional function. Cancer Res. 2005, 65, 6764-6772
188. Salah, Z.; Cohen, S.; Itzhaki, E.; Aqeilan, R.I. Nedd4 e3 ligase inhibits the activity of the hippo pathway by targeting lats1 for degradation. Cell Cycle 2013, 12, 3817-3823
189. Rossi, M.; Aqeilan, R.I.; Neale, M.; Candi, E.; Salomoni, P.; Knight, R.A.; Croce, C.M.; Melino, G. The e3 ubiquitin ligase itch controls the protein stability of p63. Proc. Natl. Acad. Sci. USA 2006, 103, 12753-12758
190. Farrell, J.; Kelly, C.; Rauch, J.; Kida, K.; Garcia-Munoz, A.; Monsefi, N.; Turriziani, B.; Doherty, C.; Mehta, J.P.; Matallanas, D.; et al. Hgf induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/mst2 and isg15 pathways. J. Proteome Res. 2014, 13, 2874-2886
191. Mohler, P.J.; Kreda, S.M.; Boucher, R.C.; Sudol, M.; Stutts, M.J.; Milgram, S.L. Yes-associated protein 65 localizes p62(c-yes) to the apical compartment of airway epithelia by association with ebp50. J. Cell Biol. 1999, 147, 879-890
192. Barry, E.R.; Morikawa, T.; Butler, B.L.; Shrestha, K.; de la Rosa, R.; Yan, K.S.; Fuchs, C.S.; Magness, S.T.; Smits, R.; Ogino, S.; et al. Restriction of intestinal stem cell expansion and the regenerative response by yap. Nature 2013, 493, 106-110
193. Bui, D.A.; Lee, W.; White, A.E.; Harper, J.W.; Schackmann, R.C.; Overholtzer, M.; Selfors, L.M.; Brugge, J.S. Cytokinesis involves a nontranscriptional function of the hippo pathway effector yap. Sci. Signal. 2016
194. Sudol, M. Yap1 oncogene and its eight isoforms. Oncogene 2013
195. Iglesias-Bexiga, M.; Castillo, F.; Cobos, E.S.; Oka, T.; Sudol, M.; Luque, I. Ww domains of the yes-kinase-associated-protein (yap) transcriptional regulator behave as independent units with different binding preferences for ppxy motif-containing ligands. PLoS ONE 2015
196. Morimoto, N.; Nagai, M.; Miyazaki, K.; Kurata, T.; Takehisa, Y.; Ikeda, Y.; Kamiya, T.; Okazawa, H.; Abe, K. Progressive decrease in the level of yapdeltacs, prosurvival isoforms of yap, in the spinal cord of transgenic mouse carrying a mutant sod1 gene. J. Neurosci. Res. 2009, 87, 928-936
197. Hoshino, M.; Qi, M.L.; Yoshimura, N.; Miyashita, T.; Tagawa, K.; Wada, Y.; Enokido, Y.; Marubuchi, S.; Harjes, P.; Arai, N.; et al. Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of yap isoforms and p73. J. Cell Biol. 2006, 172, 589-604
198. Di Agostino, S.; Sorrentino, G.; Ingallina, E.; Valenti, F.; Ferraiuolo, M.; Bicciato, S.; Piazza, S.; Strano, S.; del Sal, G.; Blandino, G. Yap enhances the pro-proliferative transcriptional activity of mutant p53 proteins. EMBO Rep. 2016, 17, 188-201
199. Brodowska, K.; Al-Moujahed, A.; Marmalidou, A.; Meyer Zu Horste, M.; Cichy, J.; Miller, J.W.; Gragoudas, E.; Vavvas, D.G. The clinically used photosensitizer verteporfin (vp) inhibits yap-tead and human retinoblastoma cell growth in vitro without light activation. Exp. Eye. Res. 2014, 124, 67-73
200. Liu-Chittenden, Y.; Huang, B.; Shim, J.S.; Chen, Q.; Lee, S.J.; Anders, R.A.; Liu, J.O.; Pan, D. Genetic and pharmacological disruption of the tead-yap complex suppresses the oncogenic activity of yap. Genes Dev. 2012, 26, 1300-1305
201. Matallanas, D.; Crespo, P. New druggable targets in the ras pathway? Curr. Opin. Mol. Ther. 2010, 12, 674-683
202. McCubrey, J.A.; Steelman, L.S.; Kempf, C.R.; Chappell, W.H.; Abrams, S.L.; Stivala, F.; Malaponte, G.; Nicoletti, F.; Libra, M.; Basecke, J.; et al. Therapeutic resistance resulting from mutations in raf/mek/erk and pi3k/pten/akt/mtor signaling pathways. J. Cell Physiol. 2011, 226, 2762-2781
203. Shtivelman, E.; Davies, M.Q.; Hwu, P.; Yang, J.; Lotem, M.; Oren, M.; Flaherty, K.T.; Fisher, D.E. Pathways and therapeutic targets in melanoma. Oncotarget 2014, 5, 1701-1752
204. Moschos, S.J.; Pinnamaneni, R. Targeted therapies in melanoma. Surg. Oncol. Clin. N. Am. 2015, 24, 347-358
205. Weinstein, J.N.; Collisson, E.A.; Mills, G.B.; Shaw, K.R.; Ozenberger, B.A.; Ellrott, K.; Shmulevich, I.; Sander, C.; Stuart, J.M. The cancer genome atlas pan-cancer analysis project. Nat. Genet. 2013, 45, 1113-1120
206. Zhang, X.; Guo, C.; Wu, X.; Li, A.X.; Liu, L.; Tsark, W.; Dammann, R.; Shen, H.; Vonderfecht, S.L.; Pfeifer, G.P. Analysis of liver tumor-prone mouse models of the hippo kinase scaffold proteins rassf1a and sav1. Cancer Res. 2016
207. Arzumanyan, A.; Reis, H.M.; Feitelson, M.A. Pathogenic mechanisms in hbv-and hcv-associated hepatocellular carcinoma. Nat. Rev. Cancer 2013, 13, 123-135
208. Nishida, N.; Nagasaka, T.; Nishimura, T.; Ikai, I.; Boland, C.R.; Goel, A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 2008, 47, 908-918
209. Yang, L.; Ma, Z.; Wang, D.; Zhao, W.; Chen, L.; Wang, G. Microrna-602 regulating tumor suppressive gene rassf1a is overexpressed in hepatitis b virus-infected liver and hepatocellular carcinoma. Cancer Biol. Ther. 2010, 9, 803-808
210. Zekri, A.R.; Bahnasy, A.A.; Shoeab, F.E.; Mohamed, W.S.; El-Dahshan, D.H.; Ali, F.T.; Sabry, G.M.; Dasgupta, N.; Daoud, S.S. Methylation of multiple genes in hepatitis c virus associated hepatocellular carcinoma. J. Adv. Res. 2014, 5, 27-40
211. Golde, T.E.; Petrucelli, L. “What kills neurons in neurodegenerative diseases?”, a review series in an open access journal. Mol. Neurodegener 2009
212. Emoto, K. The growing role of the hippo-NDR kinase signalling in neuronal development and disease. J. Biochem. 2011, 150, 133-141
213. Chami, B.; Steel, A.J.; de la Monte, S.M.; Sutherland, G.T. The rise and fall of insulin signaling in alzheimer’s disease. Metab. Brain Dis. 2016
214. Santinon, G.; Pocaterra, A.; Dupont, S. Control of yap/taz activity by metabolic and nutrient-sensing pathways. Trends Cell Biol. 2016, 26, 289-299
215. Odashima, M.; Usui, S.; Takagi, H.; Hong, C.; Liu, J.; Yokota, M.; Sadoshima, J. Inhibition of endogenous mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ. Res. 2007, 100, 1344-1352
216. Xiao, Y.; Leach, J.; Wang, J.; Martin, J.F. Hippo/yap signaling in cardiac development and regeneration. Curr. Treat. Options Cardiovasc. Med. 2016
217. Hong, A.W.; Meng, Z.; Guan, K.L. The hippo pathway in intestinal regeneration and disease. Nat. Rev. Gastroenterol. Hepatol. 2016
218. Aylon, Y.; Gershoni, A.; Rotkopf, R.; Biton, I.E.; Porat, Z.; Koh, A.P.; Sun, X.; Lee, Y.; Fiel, M.I.; Hoshida, Y.; et al. The lats2 tumor suppressor inhibits srebp and suppresses hepatic cholesterol accumulation. Genes Dev. 2016, 30, 786-797